Synonyms:Voriconazole, 137234-62-9, Vfend, (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, UK-109496, Voriconzole, (+/-)-Voriconazole, Voriconazole Vfend, (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol, UK-109,496, UK 109496, VCZ, Voriconazole, (+/-)-, CHEMBL638, NSC-759888, JFU09I87TR, USG4B1CD29, CPD000466350, C16H14F3N5O, (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-, CHEBI:10023, MFCD00905717, 173967-54-9, VRC, Voriconazol, (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-((1H)-1,2,4-triazol-1-yl)-butan-2-ol, (alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))-, 188416-29-7, Voriconazolum, Vorikonazole, Voriconazole [USAN:INN:BAN], DRG-0301, SMR000466350, Vfend (TN), VFEND I.V., UNII-JFU09I87TR, DTXSID5046485, Pfizer, Voriconazole- Bio-X, Voriconazole - Vfend, (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, Voriconazole in combination with MGCD290, VORICONAZOLE [MI], VORICONAZOLE [INN], VORICONAZOLE [JAN], UNII-USG4B1CD29, VORICONAZOLE [USAN], VORICONAZOLE [VANDF], SCHEMBL36233, VORICONAZOLE [MART.], MLS000759464, MLS001424082, MLS006010028, VORICONAZOLE [USP-RS], VORICONAZOLE [WHO-DD], VORICONAZOLE [EMA EPAR], Voriconazole (JP17/USP/INN), AMY8903, Voriconazole, >=98% (HPLC), BCPP000019, DTXSID201019420, HMS2051N09, HMS3260M22, HMS3713F12, Pharmakon1600-01502346, VORICONAZOLE [ORANGE BOOK], VORICONAZOLE [EP MONOGRAPH], Tox21_500150, VORICONAZOLE [USP MONOGRAPH], Voriconazole 2.0 mg/ml in Methanol, AC-823, BDBM50333117, NSC759888, s1442, AKOS005145705, CCG-100941, CS-1227, DB00582, HY-W337569, KS-1157, NC00191, NSC 759888, NCGC00164622-04, NCGC00164622-06, NCGC00260835-01, BV164532, HY-76200, ( inverted exclamation markA)-Voriconazole, CS-0448910, SW197571-2, V0116, C07622, D00578, EN300-119515, AB00639948-04, AB00639948-06, AB00639948_07, AB00639948_08, Voriconazole, VETRANAL(TM), analytical standard, A807215, Q412236, J-006986, Z1521553720, Voriconazole, European Pharmacopoeia (EP) Reference Standard, Voriconazole, United States Pharmacopeia (USP) Reference Standard, (2R,3S)-2,3-bis(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol, 4-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methylene]-1-oxo-1,3-thiazolidin-5-one, Voriconazole, Pharmaceutical Secondary Standard: Certified Reference Material, (.ALPHA.R,.BETA.S)-A-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-4-PYRIMIDINEETHANOL, (2R,3S)-2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol, (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol, (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol, (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol, 2R,3S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol-4-Pyrimidineethanol, ?-(2,4-difluorophenyl)-5-fluoro-?-methyl-?-(1H-1,2,4-triazol-1-ylmethyl)-,?(?R,?S)-, 4-PYRIMIDINEETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-, (.ALPHA.R,.BETA.S)-REL-, 4-PYRIMIDINEETHANOL, A-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-, (.ALPHA.R,.BETA.S)-, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-rel-
Pubchem:PUBCHEM:71616
Id:37c34470-35f2-5315-a4ef-241365e5c214
Description:nan
